ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/06/15 | 1,102 | 1,116 | 1,079 | 1,079 | -26 | -2.4% | 694,500 |
| 2022/06/14 | 1,162 | 1,162 | 1,090 | 1,105 | -77 | -6.5% | 1,280,500 |
| 2022/06/13 | 1,181 | 1,199 | 1,165 | 1,182 | -29 | -2.4% | 831,600 |
| 2022/06/10 | 1,198 | 1,217 | 1,182 | 1,211 | -4 | -0.3% | 657,200 |
| 2022/06/09 | 1,196 | 1,222 | 1,190 | 1,215 | +32 | +2.7% | 639,400 |
| 2022/06/08 | 1,154 | 1,189 | 1,153 | 1,183 | +41 | +3.6% | 822,500 |
| 2022/06/07 | 1,144 | 1,151 | 1,133 | 1,142 | -12 | -1% | 449,100 |
| 2022/06/06 | 1,136 | 1,159 | 1,132 | 1,154 | +3 | +0.3% | 484,600 |
| 2022/06/03 | 1,152 | 1,162 | 1,146 | 1,151 | +19 | +1.7% | 366,200 |
| 2022/06/02 | 1,150 | 1,150 | 1,125 | 1,132 | -36 | -3.1% | 602,000 |
| 2022/06/01 | 1,155 | 1,183 | 1,155 | 1,168 | +15 | +1.3% | 428,700 |
| 2022/05/31 | 1,166 | 1,175 | 1,152 | 1,153 | -29 | -2.5% | 530,900 |
| 2022/05/30 | 1,162 | 1,183 | 1,154 | 1,182 | +39 | +3.4% | 611,800 |
| 2022/05/27 | 1,171 | 1,174 | 1,140 | 1,143 | -8 | -0.7% | 451,200 |
| 2022/05/26 | 1,147 | 1,173 | 1,146 | 1,151 | +2 | +0.2% | 529,800 |
| 2022/05/25 | 1,158 | 1,173 | 1,147 | 1,149 | -30 | -2.5% | 532,300 |
| 2022/05/24 | 1,208 | 1,220 | 1,177 | 1,179 | -59 | -4.8% | 865,600 |
| 2022/05/23 | 1,187 | 1,238 | 1,185 | 1,238 | +60 | +5.1% | 663,300 |
| 2022/05/20 | 1,149 | 1,184 | 1,146 | 1,178 | +50 | +4.4% | 497,900 |
| 2022/05/19 | 1,121 | 1,139 | 1,117 | 1,128 | -34 | -2.9% | 750,900 |
| 2022/05/18 | 1,155 | 1,176 | 1,145 | 1,162 | +11 | +1% | 436,000 |
| 2022/05/17 | 1,160 | 1,160 | 1,133 | 1,151 | ±0 | ±0% | 442,400 |
| 2022/05/16 | 1,185 | 1,216 | 1,138 | 1,151 | +11 | +1% | 1,164,000 |
| 2022/05/13 | 1,132 | 1,151 | 1,121 | 1,140 | +38 | +3.4% | 927,800 |
| 2022/05/12 | 1,156 | 1,157 | 1,102 | 1,102 | -82 | -6.9% | 1,241,700 |
| 2022/05/11 | 1,162 | 1,201 | 1,153 | 1,184 | +22 | +1.9% | 768,700 |
| 2022/05/10 | 1,157 | 1,177 | 1,146 | 1,162 | -7 | -0.6% | 748,300 |
| 2022/05/09 | 1,195 | 1,204 | 1,165 | 1,169 | -41 | -3.4% | 944,200 |
| 2022/05/06 | 1,245 | 1,245 | 1,210 | 1,210 | -44 | -3.5% | 641,400 |
| 2022/05/02 | 1,261 | 1,267 | 1,246 | 1,254 | -23 | -1.8% | 470,800 |
| 2022/04/28 | 1,264 | 1,279 | 1,264 | 1,277 | +16 | +1.3% | 407,900 |
| 2022/04/27 | 1,245 | 1,263 | 1,232 | 1,261 | -6 | -0.5% | 522,300 |
| 2022/04/26 | 1,261 | 1,273 | 1,251 | 1,267 | +14 | +1.1% | 392,400 |
| 2022/04/25 | 1,240 | 1,268 | 1,238 | 1,253 | -4 | -0.3% | 621,700 |
| 2022/04/22 | 1,265 | 1,271 | 1,247 | 1,257 | -22 | -1.7% | 654,300 |
| 2022/04/21 | 1,267 | 1,287 | 1,263 | 1,279 | -4 | -0.3% | 695,500 |
| 2022/04/20 | 1,321 | 1,321 | 1,282 | 1,283 | -30 | -2.3% | 777,500 |
| 2022/04/19 | 1,329 | 1,348 | 1,311 | 1,313 | -21 | -1.6% | 580,800 |
| 2022/04/18 | 1,344 | 1,354 | 1,322 | 1,334 | -26 | -1.9% | 459,200 |
| 2022/04/15 | 1,368 | 1,370 | 1,348 | 1,360 | -32 | -2.3% | 573,800 |
| 2022/04/14 | 1,382 | 1,404 | 1,374 | 1,392 | +4 | +0.3% | 427,900 |
| 2022/04/13 | 1,362 | 1,391 | 1,361 | 1,388 | +22 | +1.6% | 544,100 |
| 2022/04/12 | 1,391 | 1,394 | 1,363 | 1,366 | -24 | -1.7% | 425,500 |
| 2022/04/11 | 1,414 | 1,419 | 1,377 | 1,390 | -34 | -2.4% | 507,500 |
| 2022/04/08 | 1,437 | 1,438 | 1,413 | 1,424 | -3 | -0.2% | 344,500 |
| 2022/04/07 | 1,397 | 1,440 | 1,391 | 1,427 | +35 | +2.5% | 778,800 |
| 2022/04/06 | 1,427 | 1,427 | 1,384 | 1,392 | -71 | -4.9% | 1,068,300 |
| 2022/04/05 | 1,467 | 1,469 | 1,423 | 1,463 | +23 | +1.6% | 667,200 |
| 2022/04/04 | 1,420 | 1,453 | 1,407 | 1,440 | +37 | +2.6% | 603,300 |
| 2022/04/01 | 1,410 | 1,410 | 1,385 | 1,403 | -12 | -0.8% | 496,100 |
601～
650
件表示中 / 4976件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ＪＣＲファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム
